Transfection Technologies Market Report by Product Type (Reagent, Instrument, and Others), Application (Therapeutic Delivery, Bio-Medical Research, Protein Production, and Others), Transfection Method (Lipofection, Eletroporation, Nucleofection, Cotransfe

Transfection Technologies Market Report by Product Type (Reagent, Instrument, and Others), Application (Therapeutic Delivery, Bio-Medical Research, Protein Production, and Others), Transfection Method (Lipofection, Eletroporation, Nucleofection, Cotransfection, Cationic Lipid Transfection, In-Vivo Transfection, and Others), Technology (Physical Transfection, Biochemical Based Transfection, Viral-Vector Based Transfection), End-User (Research Centers and Academic Institutes, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, and Others), and Region 2024-2032

The global transfection technologies market size reached US$ 1,172.0 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 2,275.3 Million by 2032, exhibiting a growth rate (CAGR) of 7.4% during 2024-2032.

Transfection technology refers to the process of artificially introducing nucleic acid, such as Deoxyribonucleic Acid (DNA), Ribonucleic Acid (RNA) and oligonucleotides, into the cells. It is introduced using various physical, chemical and biological methods, which can assist in modifying certain properties of the cell. It involves various methods, including cotransfection, electroporation, cationic lipid transfection and in-vivo transfection. This process is commonly used for various genomic studies that include gene expression, screening, RNA interference and Vivo research, along with the bioproduction of viruses and proteins.

The increasing prevalence of cancer and various chronic lifestyle diseases is one of the key factors driving the growth of the market. Furthermore, widespread adoption of reagent-based methods is also providing a boost to the market growth. In comparison to the traditionally used techniques, reagent-based transfection is less complicated to administer and more cost-effective. In line with this, instrument-based methods, such as biolistic technology, microinjection and laserfection, are also gaining immense traction across the globe. Various technological advancements in cell research and therapeutic discovery are acting as another major growth-inducing factor. In line with this, research in gene transfer is majorly performed under in-vivo conditions for the development of novel therapeutic drugs and various other applications. Other factors, including increasing investments by both government and private organizations to develop large scale transfection facilities, along with extensive research and development (R&D) activities in the field of protein therapeutics, are projected to drive the market further.


Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global transfection technologies market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product type, application, transfection method, technology and end-user.

Breakup by Product Type:

Reagent
Instrument
Others

Breakup by Application:

Therapeutic Delivery
Bio-Medical Research
Protein Production
Others

Breakup by Transfection Method:

Lipofection
Eletroporation
Nucleofection
Cotransfection
Cationic Lipid Transfection
In-Vivo Transfection
Others

Breakup by Technology:

Physical Transfection
Biochemical Based Transfection
Viral-Vector Based Transfection

Breakup by End-User:

Research Centers and Academic Institutes
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Others

Breakup by Region:

North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies Inc., Bio-RAD Laboratories Inc., Lonza Group AG, Maxcyte Inc., Mirus Bio LLC, Polyplus Transfection, Promega Corporation, Roche Holding AG, Sigma-Aldrich Corporation, Thermo Fisher Scientific Inc., etc.

Key Questions Answered in This Report

1. What was the size of the global transfection technologies market in 2023?
2. What is the expected growth rate of the global transfection technologies market during 2024-2032?
3. What are the key factors driving the global transfection technologies market?
4. What has been the impact of COVID-19 on the global transfection technologies market?
5. What is the breakup of the global transfection technologies market based on the product type?
6. What is the breakup of the global transfection technologies market based on the application?
7. What is the breakup of the global transfection technologies market based on the transfection method?
8. What is the breakup of the global transfection technologies market based on the technology?
9. What are the key regions in the global transfection technologies market?
10. Who are the key players/companies in the global transfection technologies market?